Nabriva Therapeutics PLC
Change company Symbol lookup
Select an option...
NBRV Nabriva Therapeutics PLC
CHUY Chuy's Holdings Inc
HBUV Hubilu Venture Corporation
LMNL Liminal BioSciences Inc
NXTD NXT-ID Inc
RIOT Riot Blockchain Inc
HIHO Highway Holdings Ltd
CBAY Cymabay Therapeutics Inc
DTSS Datasea Inc
MOXC Moxian Inc
Go

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Pharmaceuticals | Small Cap Growth
Based in Ireland
Company profile

Nabriva Therapeutics plc is a biopharmaceutical company engaged in the commercialization and development of anti-infective agents to treat serious infections. The Company’s product XENLETA (lefamulin), is a semi-synthetic pleuromutilin antibiotic for systematic administration in humans. It inhibits the synthesis of bacterial protein, which is required for bacteria to grow by binding with high affinity, high specificity and at molecular targets that are different than other antibiotic classes. The Company is also developing CONTEPO (fosfomycin) for injection, a potential first-in-class epoxide antibiotic for complicated urinary tract infections (cUTI), including acute pyelonephritis.

Closing Price
$0.776
Day's Change
0.016 (2.11%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.7789
Day's Low
0.7503
Volume
(Light)
Volume:
2,205,316

10-day average volume:
5,953,552
2,205,316
  • Prev Close
    0.76
  • Today's Open
    0.77
  • Day's Range
    0.7503-0.7789
  • Avg Vol (10-day)
    6.0M
  • Last (time)
    3:59p ET 08/03/20
  • Last (size)
    4
  • 52-Wk Range
    0.485 - 2.77
    LowHigh
  • (08/20/19 - 04/21/20)
    60.00%
  • 117.1%
  • Market Cap
    110.9M
  • Shares Outstanding
    143.0M
  • -1.31
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 2.4
  • 23.21
  • (% of float 07/15/20)
    5.68

Latest News

August 03, 2020
7:00 am ET
Globe Newswire
July 30, 2020
4:01 pm ET
Globe Newswire
July 28, 2020
10:02 am ET
Globe Newswire
July 23, 2020
7:05 am ET
Globe Newswire
July 22, 2020
8:04 am ET
Globe Newswire
July 16, 2020
4:04 pm ET
Globe Newswire
9:31 am ET
PR Newswire
July 15, 2020
4:01 pm ET
Globe Newswire
July 06, 2020
7:00 am ET
BusinessWire
June 19, 2020
8:52 pm ET
Globe Newswire
May 29, 2020
7:31 pm ET
Globe Newswire
8:00 am ET
Globe Newswire
May 27, 2020
4:01 pm ET
Globe Newswire
May 18, 2020
8:00 am ET
Globe Newswire
May 11, 2020
4:01 pm ET
Globe Newswire
7:00 am ET
Globe Newswire
May 08, 2020
7:00 am ET
Globe Newswire
March 19, 2020
8:12 am ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.